Evidence map›Paper›PMID 30035080›Full record

ArticleJournal of orthopaedic translation2016

Translational potential of ginsenoside Rb1 in managing progression of osteoarthritis.

Yuanfeng Chen, Sien Lin, Yuxin Sun, Xiaohua Pan, Liubin Xiao, Liyi Zou, Ki Wai Ho, Gang Li

Open access · goldAbstract read
In one paragraph

Article in Journal of orthopaedic translation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Ginsenoside Compound K Enhances Fracture HealingFrontiers in pharmacology · 2022
    Article
  7. Article
  8. Pharmacological activities of ginsenoside Rg5 (Review).Experimental and therapeutic medicine · 2021
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Yuanfeng ChenDepartment of Orthopaedics and Traumatology, Li Ka Shing Institute of Health Sciences and Lui Che Woo Institute of Innovative Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Sien LinDepartment of Orthopaedics and Traumatology, Li Ka Shing Institute of Health Sciences and Lui Che Woo Institute of Innovative Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Yuxin SunDepartment of Orthopaedics and Traumatology, Li Ka Shing Institute of Health Sciences and Lui Che Woo Institute of Innovative Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Xiaohua PanDepartment of Orthopaedics and Traumatology, Bao-An District People's Hospital, Shenzhen, China.
Liubin XiaoPeople's Hospital of New District Longhua, Shenzhen, China.
Liyi ZouDepartment of Pharmacology, Guangdong Medical University, Dongguan, China.
Ki Wai HoDepartment of Orthopaedics and Traumatology, Li Ka Shing Institute of Health Sciences and Lui Che Woo Institute of Innovative Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Gang LiDepartment of Orthopaedics and Traumatology, Li Ka Shing Institute of Health Sciences and Lui Che Woo Institute of Innovative Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Prince of Wales Hospital · CNChinese University of Hong Kong, Shenzhen · CNGuangdong Medical College · CNShenzhen Bao'an District People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteoarthritis (OA) is the most common degenerative joint disorder. Inflammatory cytokine plays an important role in OA progression. Previous studies have demonstrated that ginsenoside Rb1 would prevent inflammation and apoptosis in chondrocytes. However, we have not found any animal study reporting that Rb1 attenuates the severity of OA.

objectiveIn this study, we used a rat anterior cruciate ligament transaction plus medial meniscus resection (ACLT + MMx) model of OA and a cell model, to investigate whether administration of ginsenoside Rb1 may attenuate the progression of arthritis.

methodsIn this

resultsIn this

conclusionIn the present study, we demonstrated that Rb1 can attenuate the progression or severity of arthritis by reducing inflammation.

Indexed as

cartilageginsenoside Rb1inflammationosteoarthritis

Identifiers

PMID30035080
PMCPMC5987022
OpenAlexW2342756976

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.